Real-world experience of eltrombopag in immune thrombocytopenia

Immune thrombocytopenia (ITP) is characterized by decreased platelet count in the peripheral circulation. The first-line therapy is corticosteroids with 53-80% overall response rate. Eltrombopag has been used as second-line therapy in ITP for over a decade now. The long-term efficacy and safety prof...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Blood Res
Päätekijät: Mishra, Kundan, Pramanik, Suman, Jandial, Aditya, Sahu, Kamal Kant, Sandal, Rajeev, Ahuja, Ankur, Yanamandra, Uday, Kumar, Rajiv, Kapoor, Rajan, Verma, Tarun, Sharma, Sanjeevan, Singh, Jasjit, Das, Satyaranjan, Chatterjee, Tathagata, Sharma, Ajay, Nair, Velu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: e-Century Publishing Corporation 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675127/
https://ncbi.nlm.nih.gov/pubmed/33224568
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia